Submit Your Article CMED MEACR meeting
An official publication of the Middle-Eastern Association for Cancer Research
Clinical Cancer Investigation Journal
ISSN Print: 2278-1668, Online: 2278-0513
ARTICLE
Year: 2015   |   Volume: 4   |   Issue: 2   |   Page: 243-245     View issue

Early diagnosis and prompt therapy can save one′s eye


,
Abstract

Myeloid sarcoma (MS) also known as granulocytic sarcoma or chloroma, is a rare extramedullary tumor of immature myeloid cells. MS is reported in 2.5-9.1% of patients with acute myeloid leukemia (AML) and occurs concomitantly, following or rarely, antedating the onset of systemic bone marrow leukemia. Orbital involvement by acute MS is relatively rare. However, in the setting of simultaneous bilateral orbital tumors in children, MS appears to be a highly likely, if not the most likely, diagnostic possibility. Any child with an orbital mass of uncertain origin, particularly if it is a bilateral, should undergo prompt evaluation for underlying AML. Early diagnosis and prompt therapy can save one′s eyes.

Cite this article
Vancouver
Mandal P, Dolai T. Early diagnosis and prompt therapy can save one′s eye. Clin Cancer Investig J. 2015;4(2):243-5. https://doi.org/10.4103/2278-0513.148911
APA
Mandal, P., & Dolai, T. (2015). Early diagnosis and prompt therapy can save one′s eye. Clinical Cancer Investigation Journal, 4(2), 243-245. https://doi.org/10.4103/2278-0513.148911

© Clinical Cancer Investigation Journal
Online since 01 December, 2011
Creative Commons License 
ISSN Print: 2278-1668, Online: 2278-0513